25 XP   0   0   10

Hester Biosciences Limited
Buy, Hold or Sell?

Let's analyse Hester together

PenkeI guess you are interested in Hester Biosciences Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hester Biosciences Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hester Biosciences Limited

I send you an email if I find something interesting about Hester Biosciences Limited.

Quick analysis of Hester (30 sec.)










What can you expect buying and holding a share of Hester? (30 sec.)

How much money do you get?

How much money do you get?
INR0.48
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR343.70
Expected worth in 1 year
INR461.20
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR157.50
Return On Investment
9.3%

For what price can you sell your share?

Current Price per Share
INR1,691.35
Expected price per share
INR1,458 - INR1,750
How sure are you?
50%

1. Valuation of Hester (5 min.)




Live pricePrice per Share (EOD)

INR1,691.35

Intrinsic Value Per Share

INR-958.43 - INR-322.77

Total Value Per Share

INR-614.73 - INR20.93

2. Growth of Hester (5 min.)




Is Hester growing?

Current yearPrevious yearGrowGrow %
How rich?$35m$32m$2.9m8.5%

How much money is Hester making?

Current yearPrevious yearGrowGrow %
Making money$3.1m$4.7m-$1.5m-47.7%
Net Profit Margin10.0%16.7%--

How much money comes from the company's main activities?

3. Financial Health of Hester (5 min.)




What can you expect buying and holding a share of Hester? (5 min.)

Welcome investor! Hester's management wants to use your money to grow the business. In return you get a share of Hester.

What can you expect buying and holding a share of Hester?

First you should know what it really means to hold a share of Hester. And how you can make/lose money.

Speculation

The Price per Share of Hester is INR1,691. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hester.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hester, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR343.70. Based on the TTM, the Book Value Change Per Share is INR29.37 per quarter. Based on the YOY, the Book Value Change Per Share is INR36.95 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR10.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hester.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.380.0%0.380.0%0.550.0%0.480.0%0.370.0%
Usd Book Value Change Per Share0.350.0%0.350.0%0.440.0%0.420.0%0.320.0%
Usd Dividend Per Share0.120.0%0.120.0%0.120.0%0.110.0%0.080.0%
Usd Total Gains Per Share0.470.0%0.470.0%0.560.0%0.530.0%0.400.0%
Usd Price Per Share18.27-18.27-32.56-20.69-14.38-
Price to Earnings Ratio48.65-48.65-58.71-42.64-34.66-
Price-to-Total Gains Ratio38.68-38.68-57.79-39.08-37.13-
Price to Book Ratio4.43-4.43-8.63-6.21-5.47-
Price-to-Total Gains Ratio38.68-38.68-57.79-39.08-37.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.2962
Number of shares49
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.120.11
Usd Book Value Change Per Share0.350.42
Usd Total Gains Per Share0.470.53
Gains per Quarter (49 shares)23.1525.91
Gains per Year (49 shares)92.61103.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1246983228194
24713817644163198
37120726966244302
49427636289326406
5118345455111407510
6141415548133489614
7165484641155570718
8188553734177652822
9212622827199733926
102356919202228151030

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%

Fundamentals of Hester

About Hester Biosciences Limited

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare, and Others segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, fowl typhoid, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian coccidiosis, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucellosis, contagious bovine pleuropneumonia, and lumpy skin diseases. In addition, the company provides animal health products, such as biosecurity and therapeutic solutions, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticide solutions, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides enzyme-linked immunosorbent assay and polymerase chain reaction diagnostic kits. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Fundamental data was last updated by Penke on 2024-04-14 01:17:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hester Biosciences Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hester earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Hester to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 10.0% means that ₹0.10 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hester Biosciences Limited:

  • The MRQ is 10.0%. The company is making a huge profit. +2
  • The TTM is 10.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.0%TTM10.0%0.0%
TTM10.0%YOY16.7%-6.7%
TTM10.0%5Y16.4%-6.4%
5Y16.4%10Y16.6%-0.2%
1.1.2. Return on Assets

Shows how efficient Hester is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hester to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.9% Return on Assets means that Hester generated ₹0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hester Biosciences Limited:

  • The MRQ is 4.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.9%0.0%
TTM4.9%YOY7.0%-2.1%
TTM4.9%5Y8.3%-3.5%
5Y8.3%10Y8.8%-0.4%
1.1.3. Return on Equity

Shows how efficient Hester is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hester to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.1% Return on Equity means Hester generated ₹0.09 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hester Biosciences Limited:

  • The MRQ is 9.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.1%TTM9.1%0.0%
TTM9.1%YOY15.1%-6.0%
TTM9.1%5Y15.4%-6.3%
5Y15.4%10Y16.2%-0.7%

1.2. Operating Efficiency of Hester Biosciences Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hester is operating .

  • Measures how much profit Hester makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hester to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 18.6% means the company generated ₹0.19  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hester Biosciences Limited:

  • The MRQ is 18.6%. The company is operating efficient. +1
  • The TTM is 18.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ18.6%TTM18.6%0.0%
TTM18.6%YOY24.7%-6.1%
TTM18.6%5Y26.6%-8.0%
5Y26.6%10Y26.3%+0.3%
1.2.2. Operating Ratio

Measures how efficient Hester is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.89 means that the operating costs are ₹0.89 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Hester Biosciences Limited:

  • The MRQ is 0.888. The company is less efficient in keeping operating costs low.
  • The TTM is 0.888. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.888TTM0.8880.000
TTM0.888YOY0.760+0.128
TTM0.8885Y0.753+0.135
5Y0.75310Y0.742+0.011

1.3. Liquidity of Hester Biosciences Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hester is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.58 means the company has ₹1.58 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Hester Biosciences Limited:

  • The MRQ is 1.583. The company is able to pay all its short-term debts. +1
  • The TTM is 1.583. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.583TTM1.5830.000
TTM1.583YOY2.010-0.427
TTM1.5835Y2.219-0.636
5Y2.21910Y1.951+0.268
1.3.2. Quick Ratio

Measures if Hester is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hester to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.95 means the company can pay off ₹0.95 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hester Biosciences Limited:

  • The MRQ is 0.946. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.946. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.946TTM0.9460.000
TTM0.946YOY1.245-0.299
TTM0.9465Y1.339-0.393
5Y1.33910Y1.041+0.299

1.4. Solvency of Hester Biosciences Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hester assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hester to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Hester assets are financed with 46.4% credit (debt) and the remaining percentage (100% - 46.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hester Biosciences Limited:

  • The MRQ is 0.464. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.464. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.464TTM0.4640.000
TTM0.464YOY0.524-0.060
TTM0.4645Y0.455+0.010
5Y0.45510Y0.448+0.007
1.4.2. Debt to Equity Ratio

Measures if Hester is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hester to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 86.7% means that company has ₹0.87 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hester Biosciences Limited:

  • The MRQ is 0.867. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.867. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.867TTM0.8670.000
TTM0.867YOY1.134-0.267
TTM0.8675Y0.864+0.003
5Y0.86410Y0.840+0.024

2. Market Valuation of Hester Biosciences Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Hester generates.

  • Above 15 is considered overpriced but always compare Hester to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 48.65 means the investor is paying ₹48.65 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hester Biosciences Limited:

  • The EOD is 54.036. Based on the earnings, the company is expensive. -2
  • The MRQ is 48.651. Based on the earnings, the company is overpriced. -1
  • The TTM is 48.651. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD54.036MRQ48.651+5.385
MRQ48.651TTM48.6510.000
TTM48.651YOY58.705-10.055
TTM48.6515Y42.642+6.009
5Y42.64210Y34.656+7.986
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hester Biosciences Limited:

  • The EOD is -26.563. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.916. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -23.916. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-26.563MRQ-23.916-2.647
MRQ-23.916TTM-23.9160.000
TTM-23.916YOY-26.562+2.646
TTM-23.9165Y14.590-38.506
5Y14.59010Y48.976-34.386
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hester is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 4.43 means the investor is paying ₹4.43 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Hester Biosciences Limited:

  • The EOD is 4.921. Based on the equity, the company is fair priced.
  • The MRQ is 4.431. Based on the equity, the company is fair priced.
  • The TTM is 4.431. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.921MRQ4.431+0.490
MRQ4.431TTM4.4310.000
TTM4.431YOY8.633-4.202
TTM4.4315Y6.206-1.775
5Y6.20610Y5.466+0.740
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hester Biosciences Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--29.37429.3740%36.953-21%34.650-15%26.318+12%
Book Value Per Share--343.701343.7010%314.327+9%278.218+24%201.900+70%
Current Ratio--1.5831.5830%2.010-21%2.219-29%1.951-19%
Debt To Asset Ratio--0.4640.4640%0.524-11%0.455+2%0.448+4%
Debt To Equity Ratio--0.8670.8670%1.134-24%0.864+0%0.840+3%
Dividend Per Share--10.00010.0000%10.0000%9.419+6%6.886+45%
Eps--31.30131.3010%46.221-32%40.230-22%30.861+1%
Free Cash Flow Per Share---63.673-63.6730%-102.155+60%-31.364-51%-12.905-80%
Free Cash Flow To Equity Per Share---14.586-14.5860%29.045-150%5.411-370%4.728-408%
Gross Profit Margin--0.0110.0110%0.560-98%0.386-97%0.540-98%
Intrinsic Value_10Y_max---322.775--------
Intrinsic Value_10Y_min---958.431--------
Intrinsic Value_1Y_max---17.134--------
Intrinsic Value_1Y_min---61.101--------
Intrinsic Value_3Y_max---63.073--------
Intrinsic Value_3Y_min---214.934--------
Intrinsic Value_5Y_max---122.987--------
Intrinsic Value_5Y_min---401.946--------
Market Cap14388077661.000+10%12954254022.00012954254022.0000%23082952834.250-44%14666260603.250-12%10195264544.475+27%
Net Profit Margin--0.1000.1000%0.167-40%0.164-39%0.166-40%
Operating Margin--0.1860.1860%0.247-25%0.266-30%0.263-29%
Operating Ratio--0.8880.8880%0.760+17%0.753+18%0.742+20%
Pb Ratio4.921+10%4.4314.4310%8.633-49%6.206-29%5.466-19%
Pe Ratio54.036+10%48.65148.6510%58.705-17%42.642+14%34.656+40%
Price Per Share1691.350+10%1522.8001522.8000%2713.450-44%1724.050-12%1198.475+27%
Price To Free Cash Flow Ratio-26.563-11%-23.916-23.9160%-26.562+11%14.590-264%48.976-149%
Price To Total Gains Ratio42.956+10%38.67538.6750%57.791-33%39.075-1%37.131+4%
Quick Ratio--0.9460.9460%1.245-24%1.339-29%1.041-9%
Return On Assets--0.0490.0490%0.070-30%0.083-42%0.088-44%
Return On Equity--0.0910.0910%0.151-40%0.154-41%0.162-44%
Total Gains Per Share--39.37439.3740%46.953-16%44.069-11%33.204+19%
Usd Book Value--35085840.00035085840.0000%32087280.000+9%28401197.059+24%20610429.863+70%
Usd Book Value Change Per Share--0.3520.3520%0.443-21%0.416-15%0.316+12%
Usd Book Value Per Share--4.1244.1240%3.772+9%3.339+24%2.423+70%
Usd Dividend Per Share--0.1200.1200%0.1200%0.113+6%0.083+45%
Usd Eps--0.3760.3760%0.555-32%0.483-22%0.370+1%
Usd Free Cash Flow---6499920.000-6499920.0000%-10428240.000+60%-3201743.465-51%-1317323.208-80%
Usd Free Cash Flow Per Share---0.764-0.7640%-1.226+60%-0.376-51%-0.155-80%
Usd Free Cash Flow To Equity Per Share---0.175-0.1750%0.349-150%0.065-370%0.057-408%
Usd Market Cap172656931.932+10%155451048.264155451048.2640%276995434.011-44%175995127.239-12%122343174.534+27%
Usd Price Per Share20.296+10%18.27418.2740%32.561-44%20.689-12%14.382+27%
Usd Profit--3195240.0003195240.0000%4718400.000-32%4106767.956-22%3131843.338+2%
Usd Revenue--31930920.00031930920.0000%28200720.000+13%25842340.277+24%19156646.112+67%
Usd Total Gains Per Share--0.4720.4720%0.563-16%0.529-11%0.398+19%
 EOD+5 -3MRQTTM+0 -0YOY+12 -225Y+9 -2710Y+19 -17

3.2. Fundamental Score

Let's check the fundamental score of Hester Biosciences Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1554.036
Price to Book Ratio (EOD)Between0-14.921
Net Profit Margin (MRQ)Greater than00.100
Operating Margin (MRQ)Greater than00.186
Quick Ratio (MRQ)Greater than10.946
Current Ratio (MRQ)Greater than11.583
Debt to Asset Ratio (MRQ)Less than10.464
Debt to Equity Ratio (MRQ)Less than10.867
Return on Equity (MRQ)Greater than0.150.091
Return on Assets (MRQ)Greater than0.050.049
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Hester Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.771
Ma 20Greater thanMa 501,590.415
Ma 50Greater thanMa 1001,471.483
Ma 100Greater thanMa 2001,482.399
OpenGreater thanClose1,666.950
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets5,458,150
Total Liabilities2,534,330
Total Stockholder Equity2,923,820
 As reported
Total Liabilities 2,534,330
Total Stockholder Equity+ 2,923,820
Total Assets = 5,458,150

Assets

Total Assets5,458,150
Total Current Assets2,160,480
Long-term Assets3,297,670
Total Current Assets
Cash And Cash Equivalents 43,010
Short-term Investments 183,070
Net Receivables 882,070
Inventory 792,160
Other Current Assets 260,170
Total Current Assets  (as reported)2,160,480
Total Current Assets  (calculated)2,160,480
+/-0
Long-term Assets
Property Plant Equipment 2,539,840
Intangible Assets 28,400
Other Assets 45,800
Long-term Assets  (as reported)3,297,670
Long-term Assets  (calculated)2,614,040
+/- 683,630

Liabilities & Shareholders' Equity

Total Current Liabilities1,364,700
Long-term Liabilities1,169,630
Total Stockholder Equity2,923,820
Total Current Liabilities
Short-term Debt 809,250
Short Long Term Debt 809,250
Accounts payable 287,110
Other Current Liabilities 99,660
Total Current Liabilities  (as reported)1,364,700
Total Current Liabilities  (calculated)2,005,270
+/- 640,570
Long-term Liabilities
Long term Debt Total 1,904,770
Capital Lease Obligations Min Short Term Debt-747,560
Long-term Liabilities Other 240,000
Long-term Liabilities  (as reported)1,169,630
Long-term Liabilities  (calculated)1,397,210
+/- 227,580
Total Stockholder Equity
Common Stock85,070
Retained Earnings 2,030,420
Accumulated Other Comprehensive Income 506,740
Capital Surplus 175,070
Total Stockholder Equity (as reported)2,923,820
Total Stockholder Equity (calculated)2,797,300
+/- 126,520
Other
Capital Stock85,070
Cash and Short Term Investments 226,080
Common Stock Shares Outstanding 8,507
Current Deferred Revenue168,680
Liabilities and Stockholders Equity 5,458,150
Net Debt 1,600,210
Net Invested Capital 4,567,040
Net Working Capital 795,780
Property Plant and Equipment Gross 2,539,840
Short Long Term Debt Total 1,643,220



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
> Total Assets 
638,388
686,420
745,196
809,899
890,873
954,258
1,236,996
1,422,218
1,597,319
1,842,801
2,181,259
2,440,421
2,994,514
3,844,767
4,110,490
5,621,610
5,458,150
5,458,1505,621,6104,110,4903,844,7672,994,5142,440,4212,181,2591,842,8011,597,3191,422,2181,236,996954,258890,873809,899745,196686,420638,388
   > Total Current Assets 
300,864
296,347
366,047
411,076
473,333
461,242
498,020
570,999
571,324
726,525
803,911
984,474
1,426,773
1,576,177
1,615,060
1,947,630
2,160,480
2,160,4801,947,6301,615,0601,576,1771,426,773984,474803,911726,525571,324570,999498,020461,242473,333411,076366,047296,347300,864
       Cash And Cash Equivalents 
0
0
0
0
0
36,999
26,287
48,529
80,893
52,835
119,567
130,781
416,691
230,853
208,070
242,730
43,010
43,010242,730208,070230,853416,691130,781119,56752,83580,89348,52926,28736,99900000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
479
7,506
10,219
4
2,930
14,000
183,070
183,07014,0002,930410,2197,5064790000000000
       Net Receivables 
0
0
0
0
0
0
0
140,617
177,611
262,389
265,843
324,283
437,064
683,834
771,440
936,130
882,070
882,070936,130771,440683,834437,064324,283265,843262,389177,611140,6170000000
       Other Current Assets 
300,864
296,347
366,047
411,076
473,333
148,615
160,711
166,578
199,346
337,485
350,229
456,120
65,165
21,817
10,400
950
260,170
260,17095010,40021,81765,165456,120350,229337,485199,346166,578160,711148,615473,333411,076366,047296,347300,864
   > Long-term Assets 
337,524
390,073
379,149
398,823
417,540
493,016
738,976
851,219
1,025,995
1,116,276
1,377,349
1,455,947
1,567,742
2,268,590
2,495,440
3,673,980
3,297,670
3,297,6703,673,9802,495,4402,268,5901,567,7421,455,9471,377,3491,116,2761,025,995851,219738,976493,016417,540398,823379,149390,073337,524
       Property Plant Equipment 
354,334
409,044
405,308
398,362
392,159
456,079
665,409
742,781
907,142
1,004,211
1,232,058
1,412,439
1,546,714
2,209,391
2,442,790
3,373,920
2,539,840
2,539,8403,373,9202,442,7902,209,3911,546,7141,412,4391,232,0581,004,211907,142742,781665,409456,079392,159398,362405,308409,044354,334
       Goodwill 
0
0
0
0
0
0
0
0
0
2,660
2,100
1,541
0
0
0
0
0
000001,5412,1002,660000000000
       Long Term Investments 
0
0
0
0
0
0
0
2,779
2,779
683
4,749
806
5,604
0
0
0
0
00005,6048064,7496832,7792,7790000000
       Intangible Assets 
0
0
0
0
0
902
0
926
2,913
4,032
4,982
4,951
4,799
3,931
4,210
20,450
28,400
28,40020,4504,2103,9314,7994,9514,9824,0322,913926090200000
       Other Assets 
0
0
0
0
0
0
0
104,734
79,654
8,060
85,202
34,832
43,423
67,360
-10
242,170
45,800
45,800242,170-1067,36043,42334,83285,2028,06079,654104,7340000000
> Total Liabilities 
358,918
351,727
378,726
401,257
411,018
343,656
552,047
659,339
758,735
794,662
939,354
990,403
1,182,963
1,779,837
1,750,900
2,947,670
2,534,330
2,534,3302,947,6701,750,9001,779,8371,182,963990,403939,354794,662758,735659,339552,047343,656411,018401,257378,726351,727358,918
   > Total Current Liabilities 
135,341
150,301
191,336
172,758
171,931
282,194
388,943
454,740
384,884
385,263
403,688
546,316
486,607
813,393
613,660
968,980
1,364,700
1,364,700968,980613,660813,393486,607546,316403,688385,263384,884454,740388,943282,194171,931172,758191,336150,301135,341
       Short-term Debt 
0
0
0
0
0
0
160,960
297,375
234,421
210,430
183,156
322,412
314,986
445,269
216,730
583,540
809,250
809,250583,540216,730445,269314,986322,412183,156210,430234,421297,375160,960000000
       Short Long Term Debt 
0
0
0
0
0
0
0
478,181
28,700
45,096
183,156
320,231
314,218
440,428
32,790
580,270
809,250
809,250580,27032,790440,428314,218320,231183,15645,09628,700478,1810000000
       Accounts payable 
0
0
0
0
0
0
57,077
45,211
47,481
58,434
74,696
78,989
87,516
186,142
280,860
180,190
287,110
287,110180,190280,860186,14287,51678,98974,69658,43447,48145,21157,077000000
       Other Current Liabilities 
135,341
150,301
191,336
172,758
171,931
282,194
170,905
112,155
102,981
116,399
145,836
125,048
52,018
160,910
26,360
34,010
99,660
99,66034,01026,360160,91052,018125,048145,836116,399102,981112,155170,905282,194171,931172,758191,336150,301135,341
   > Long-term Liabilities 
223,577
201,426
187,389
228,499
239,087
61,462
163,104
204,599
373,851
409,399
535,666
444,087
696,356
966,444
1,137,240
1,978,690
1,169,630
1,169,6301,978,6901,137,240966,444696,356444,087535,666409,399373,851204,599163,10461,462239,087228,499187,389201,426223,577
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
330,930
446,210
365,393
583,512
816,692
828,420
1,698,140
1,904,770
1,904,7701,698,140828,420816,692583,512365,393446,210330,930000000000
       Other Liabilities 
0
0
0
0
0
0
0
49,400
58,703
81,826
36,963
78,695
112,844
149,750
256,990
280,550
422,470
422,470280,550256,990149,750112,84478,69536,96381,82658,70349,4000000000
> Total Stockholder Equity
279,470
334,693
366,470
408,641
479,855
597,597
672,993
750,111
823,956
1,007,135
1,196,137
1,406,339
1,774,584
2,010,721
2,283,090
2,599,850
2,923,820
2,923,8202,599,8502,283,0902,010,7211,774,5841,406,3391,196,1371,007,135823,956750,111672,993597,597479,855408,641366,470334,693279,470
   Common Stock
51,912
51,912
51,912
51,912
51,912
56,712
85,068
85,068
85,068
85,069
85,069
85,069
85,069
85,069
85,070
85,070
85,070
85,07085,07085,07085,06985,06985,06985,06985,06985,06885,06885,06856,71251,91251,91251,91251,91251,912
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 
-27,888
-64,127
-102,564
-144,898
-189,677
-228,655
-272,535
-325,753
-380,542
-431,916
-497,778
-593,250
-702,036
-827,704
480,480
491,590
506,740
506,740491,590480,480-827,704-702,036-593,250-497,778-431,916-380,542-325,753-272,535-228,655-189,677-144,898-102,564-64,127-27,888
   Capital Surplus 
0
0
0
0
0
0
0
0
0
175,067
175,067
175,067
175,067
175,067
175,070
175,070
175,070
175,070175,070175,070175,067175,067175,067175,067175,067000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
255,446
346,908
417,122
501,627
617,620
769,540
666,215
746,920
814,513
939,632
1,037,515
1,185,557
1,351,851
-1,729,490
175,070
175,070
301,590
301,590175,070175,070-1,729,4901,351,8511,185,5571,037,515939,632814,513746,920666,215769,540617,620501,627417,122346,908255,446



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue2,660,910
Cost of Revenue-774,860
Gross Profit1,886,0501,886,050
 
Operating Income (+$)
Gross Profit1,886,050
Operating Expense-1,586,910
Operating Income420,280299,140
 
Operating Expense (+$)
Research Development33,940
Selling General Administrative53,230
Selling And Marketing Expenses263,410
Operating Expense1,586,910350,580
 
Net Interest Income (+$)
Interest Income93,200
Interest Expense-93,200
Other Finance Cost-93,200
Net Interest Income-93,200
 
Pretax Income (+$)
Operating Income420,280
Net Interest Income-93,200
Other Non-Operating Income Expenses0
Income Before Tax (EBT)401,540439,020
EBIT - interestExpense = 401,540
387,460
359,470
Interest Expense93,200
Earnings Before Interest and Taxes (EBIT)494,740494,740
Earnings Before Interest and Taxes (EBITDA)701,690
 
After tax Income (+$)
Income Before Tax401,540
Tax Provision-121,190
Net Income From Continuing Ops280,350280,350
Net Income266,270
Net Income Applicable To Common Shares266,270
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,361,770
Total Other Income/Expenses Net-18,74093,200
 

Technical Analysis of Hester
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hester. The general trend of Hester is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hester's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hester Biosciences Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,716 < 1,720 < 1,750.

The bearish price targets are: 1,569 > 1,550 > 1,458.

Tweet this
Hester Biosciences Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hester Biosciences Limited. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hester Biosciences Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hester Biosciences Limited. The current macd is 61.61.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hester price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hester. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hester price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hester Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) ChartHester Biosciences Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hester Biosciences Limited. The current adx is 45.34.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hester shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Hester Biosciences Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hester Biosciences Limited. The current sar is 1,633.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hester Biosciences Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hester Biosciences Limited. The current rsi is 71.77. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Hester Biosciences Limited Daily Relative Strength Index (RSI) ChartHester Biosciences Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hester Biosciences Limited. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hester price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hester Biosciences Limited Daily Stochastic Oscillator ChartHester Biosciences Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hester Biosciences Limited. The current cci is 96.32.

Hester Biosciences Limited Daily Commodity Channel Index (CCI) ChartHester Biosciences Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hester Biosciences Limited. The current cmo is 47.97.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hester Biosciences Limited Daily Chande Momentum Oscillator (CMO) ChartHester Biosciences Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hester Biosciences Limited. The current willr is -7.27153619.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Hester Biosciences Limited Daily Williams %R ChartHester Biosciences Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hester Biosciences Limited.

Hester Biosciences Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hester Biosciences Limited. The current atr is 52.95.

Hester Biosciences Limited Daily Average True Range (ATR) ChartHester Biosciences Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hester Biosciences Limited. The current obv is 214,462.

Hester Biosciences Limited Daily On-Balance Volume (OBV) ChartHester Biosciences Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hester Biosciences Limited. The current mfi is 77.37.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hester Biosciences Limited Daily Money Flow Index (MFI) ChartHester Biosciences Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hester Biosciences Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Hester Biosciences Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hester Biosciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.771
Ma 20Greater thanMa 501,590.415
Ma 50Greater thanMa 1001,471.483
Ma 100Greater thanMa 2001,482.399
OpenGreater thanClose1,666.950
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hester with someone you think should read this too:
  • Are you bullish or bearish on Hester? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hester? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hester Biosciences Limited

I send you an email if I find something interesting about Hester Biosciences Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Hester Biosciences Limited.

Receive notifications about Hester Biosciences Limited in your mailbox!